A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study.
Saved in:
| Title: | A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study. |
|---|---|
| Authors: | Bafaloukos D; 1st Oncology Department, Metropolitan Hospital, Athens, Greece., Linardou H, Aravantinos G, Papadimitriou C, Bamias A, Fountzilas G, Kalofonos HP, Kosmidis P, Timotheadou E, Makatsoris T, Samantas E, Briasoulis E, Christodoulou C, Papakostas P, Pectasides D, Dimopoulos AM |
| Source: | BMC medicine [BMC Med] 2010 Jan 07; Vol. 8, pp. 3. Date of Electronic Publication: 2010 Jan 07. |
| Publication Type: | Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 20055981 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bafaloukos+D%22">Bafaloukos D</searchLink>; 1st Oncology Department, Metropolitan Hospital, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Linardou+H%22">Linardou H</searchLink><br /><searchLink fieldCode="AU" term="%22Aravantinos+G%22">Aravantinos G</searchLink><br /><searchLink fieldCode="AU" term="%22Papadimitriou+C%22">Papadimitriou C</searchLink><br /><searchLink fieldCode="AU" term="%22Bamias+A%22">Bamias A</searchLink><br /><searchLink fieldCode="AU" term="%22Fountzilas+G%22">Fountzilas G</searchLink><br /><searchLink fieldCode="AU" term="%22Kalofonos+HP%22">Kalofonos HP</searchLink><br /><searchLink fieldCode="AU" term="%22Kosmidis+P%22">Kosmidis P</searchLink><br /><searchLink fieldCode="AU" term="%22Timotheadou+E%22">Timotheadou E</searchLink><br /><searchLink fieldCode="AU" term="%22Makatsoris+T%22">Makatsoris T</searchLink><br /><searchLink fieldCode="AU" term="%22Samantas+E%22">Samantas E</searchLink><br /><searchLink fieldCode="AU" term="%22Briasoulis+E%22">Briasoulis E</searchLink><br /><searchLink fieldCode="AU" term="%22Christodoulou+C%22">Christodoulou C</searchLink><br /><searchLink fieldCode="AU" term="%22Papakostas+P%22">Papakostas P</searchLink><br /><searchLink fieldCode="AU" term="%22Pectasides+D%22">Pectasides D</searchLink><br /><searchLink fieldCode="AU" term="%22Dimopoulos+AM%22">Dimopoulos AM</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101190723%22">BMC medicine</searchLink> [BMC Med] 2010 Jan 07; Vol. 8, pp. 3. <i>Date of Electronic Publication: </i>2010 Jan 07. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101190723 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1741-7015 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2217417015%22">17417015 </searchLink><i>NLM ISO Abbreviation: </i>BMC Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=20055981 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/1741-7015-8-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3 Titles: – TitleFull: A randomized phase II study of carboplatin plus pegylated liposomal doxorubicin versus carboplatin plus paclitaxel in platinum sensitive ovarian cancer patients: a Hellenic Cooperative Oncology Group study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bafaloukos D – PersonEntity: Name: NameFull: Linardou H – PersonEntity: Name: NameFull: Aravantinos G – PersonEntity: Name: NameFull: Papadimitriou C – PersonEntity: Name: NameFull: Bamias A – PersonEntity: Name: NameFull: Fountzilas G – PersonEntity: Name: NameFull: Kalofonos HP – PersonEntity: Name: NameFull: Kosmidis P – PersonEntity: Name: NameFull: Timotheadou E – PersonEntity: Name: NameFull: Makatsoris T – PersonEntity: Name: NameFull: Samantas E – PersonEntity: Name: NameFull: Briasoulis E – PersonEntity: Name: NameFull: Christodoulou C – PersonEntity: Name: NameFull: Papakostas P – PersonEntity: Name: NameFull: Pectasides D – PersonEntity: Name: NameFull: Dimopoulos AM IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 01 Text: 2010 Jan 07 Type: published Y: 2010 Identifiers: – Type: issn-electronic Value: 1741-7015 Numbering: – Type: volume Value: 8 Titles: – TitleFull: BMC medicine Type: main |
| ResultId | 1 |
